APP and Alzheimer disease: Accordingly, an AD mouse model that express mutant amyloid precursor protein (APP) and presenilin 1 (PS1) together with SREBP-2/SREBF2 displayed enhanced Aβ accumulation and tau pathology, correlating with early oxidative damage and neuroinflammation [44].